Melanocyte research is fundamental to understanding human skin pigmentation and UV protection through regulated melanin production. Melanocyte dysfunction drives highly prevalent conditions such as melanoma, vitiligo, and diverse pigmentation disorders. Robust melanocyte research models are therefore essential for dermatology research, oncology, immunology, and cosmetic science.
Melanocytes control skin pigmentation, immune balance, and photo-response. Their dysregulation contributes to hyperpigmentation, albinism, photoaging skin damage, inflammatory skin disease, and skin cancer progression. Reproducible melanocyte systems enable in-depth study of melanin biology, pigmentation pathways, UV-induced DNA damage, and immune-mediated depigmentation, while supporting predictive human-relevant testing of cosmetic or pharmaceutical ingredients.
Reliable experiments require primary human melanocytes, standardized expansion methods, and optimized melanocyte cell culture media to ensure minimized variability and physiologically relevant function. Advanced models, including 2D and 3D skin models, replicate tissue-like environments to evaluate differentiation, co-culture dynamics, pigmentation changes, and photoaging responses. These systems strengthen translational research and next-generation therapies.
CELLnTEC’s dedicated melanocyte cell culture portfolio integrates primary human melanocytes, robust melanocyte growth medium, 2D and 3D starter kits, standardized cells, expert protocols, and deep technical expertise. This comprehensive platform enables reliable expansion, controlled differentiation, co-culture, and comprehensive characterization for discovery research, applied testing, and cosmetic safety testing.
By bridging basic research, translational dermatology, and melanocyte-based cell therapy, CELLnTEC supports advanced studies toward personalized skin treatments. Whether developing melanoma models, investigating vitiligo and immune-mediated pigmentation loss, or conducting ingredient safety and efficacy testing, researchers gain reproducible, predictive melanocyte systems aligned with modern dermatology research and cosmetic science needs.
Unified base formulation optimized for multiple melanocyte applications from expansion to co-culture and differentiation.
Supports UV exposure and DNA damage response studies.
Pigmentation and melanin production with controlled melanocyte differentiation.
Trusted by researchers worldwide, developing advanced in vitro skin models for pharma and cosmetics.
Vitiligo research, immune-mediated melanocyte loss, and repigmentation strategies.
Melanogenesis pathway mapping and regulation of melanin synthesis in vitro.
UV-induced DNA damage, oxidative stress, and photoprotection studies.
Screening of pro- and anti-pigmenting compounds for cosmetic and therapeutic pipelines.
Reconstructed 3D human skin equivalents for cosmetic ingredient safety and efficacy testing.
Melanoma biology, tumor-microenvironment interaction, and targeted therapy screening.
1
Support for melanocyte–keratinocyte co-culture to mimic in vivo cellular cross-talk and for realistic epidermal pigmentation models.
3
Feeder-free culture systems to simplify workflows, reduce variability, and maintain high cell quality.
2
Free of cholera toxin and PMA for improved regulatory alignment for ATMP-relevant workflows.
4
Compatible with melanocytes from different donor ages and anatomical sites.
Primary epithelial cells growing in CnT-NX-EX display a highly proliferative phenotype. For differentiation experiments, it is recommended to switch to the CnT-PR-D or CnT-PR-3D differentiation media.
